Stryker Corp

Common Name
Stryker
Country
United States
Sector
Healthcare
Industry
Medical Devices
Employees
53,000
Ticker
SYK
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Stryker Corporation is a global leader in the medical technology sector, specializing in the design, manufacture, and distribution of innovative healthcare products. The company operates through two p...

Financial Statements of Stryker

Below are the financial statements of Stryker, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in billions of USD202420232022
Net sales
22.6a
20.5a
18.45a
Cost of sales
-8.16a
-7.44a
-6.87a
Gross profit
14.44a
13.06a
11.58a
Research, development and engineering expenses
-1.47a
-1.39a
-1.45a
Selling, general and administrative expenses
-7.69a
-7.11a
-6.39a
Amortization of intangible assets
-0.62a
-0.64a
-0.63a
Goodwill and other impairments
-0.98a
-0.04a
-0.27a
Total operating expenses
-10.75a
-9.17a
-8.74a
Operating income
3.69a
3.89a
2.84a
Other income (expense), net
-0.2a
-0.22a
-0.16a
Earnings before income taxes
3.49a
3.67a
2.68a
Income taxes
-0.5a
-0.51a
-0.33a
Net earnings
2.99a
3.17a
2.36a

Verified Sources Behind Stryker’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Stryker’s data sources below and access millions more through our Disclosure Search.

a. Stryker's 10-K 2024
Trace every data point back to Stryker’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?